| Name | Cyclophilin inhibitor 1 |
|---|---|
| Synonyms | Spiro[20H-7,2-(butenoxyethaniminoethano[1,3]-endo-pyridazinomethaniminomethano)quinoline-11,5'-[1,3]dioxane]-12,15,18,25-tetrone, 21,22,23,24-tetrahydro-17,27-dimethyl-14-(1-methylethyl)-, (9E,14S,17S,21S,27R) |
| Description | Cyclophilin inhibitor 1 is a potent and orally bioavailable cyclophilin A inhibitor, with a Kd of 5 nM, shows effective anti-HCV activity, with an EC50 of 98 nM for HCV 2a[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 5 nM (Cyclophilin A)[1] EC50: 98 nM (HCV 2a)[1] |
| In Vitro | Cyclophilin inhibitor 1 (Compound 3) inhibits HCV 2a activity, with an EC50 of 98 nM[1]. |
| References |
| Molecular Formula | C31H39N5O7 |
|---|---|
| Molecular Weight | 593.67 |